文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气复苏、休克与脓毒症

MLKL-NLRP3介导的坏死性炎症在脓毒症诱导急性肺损伤小鼠中的作用与机制

[Role and mechanisms of MLKL-NLRP3-mediated necroinflammation in mice with sepsis-induced acute lung injury].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论脓毒症小鼠肺组织MLKL-NLRP3介导的坏死性炎症显著上调,造模前10分钟静脉注射Necrostatin-1(20 mg/kg)可减轻该炎症反应。

该研究将18只BALB/c小鼠随机分为假手术组、盲肠结扎穿孔(CLP)脓毒症模型组和特异性抑制剂Necrostatin-1干预组(CLP+Nec-1组,造模前10分钟静脉注射Necrostatin-1溶液20 mg/kg),每组6只,术后第2天断颈处死取材。结果显示,与假手术组比较,CLP组肺组织含水量、肺血管通透性(伊文思蓝含量)、肺组织p-MLKL与NLRP3蛋白表达及血清IL-1β水平均显著升高(均P<0.01)。与CLP组比较,CLP+Nec-1组上述指标均显著降低(均P<0.01),肺组织病理学改变也优于CLP组。作者认为,MLKL-NLRP3介导的坏死性炎症在脓毒症小鼠肺组织中显著上调,可被特异性抑制剂Necrostatin-1减轻。

要点

  • CLP脓毒症小鼠术后第2天肺组织含水量为(88.00±0.00)%,高于假手术组的(78.00±0.01)%(P<0.01)。
  • 造模前10分钟静脉注射Necrostatin-1(20 mg/kg)使肺组织含水量降至(81.00±0.01)%,低于CLP组的(88.00±0.00)%(P<0.01)。
  • CLP组肺血管通透性(伊文思蓝含量)为(11.82±1.15)mg/L,高于假手术组的(4.00±0.71)mg/L(P<0.01);Nec-1干预后降至(7.90±0.00)mg/L(P<0.01)。
  • CLP组血清IL-1β为(183.56±9.61)ng/L,高于假手术组的(44.14±6.95)ng/L(P<0.01);Nec-1干预后降至(113.81±6.62)ng/L(P<0.01)。
  • CLP组肺组织p-MLKL/GAPDH为0.34±0.04、NLRP3/GAPDH为0.47±0.07,均高于假手术组(分别为0.12±0.01、0.16±0.04)(均P<0.01);Nec-1干预后分别降至0.13±0.03、0.18±0.04(均P<0.01)。

适用人群与场景

  • BALB/c小鼠,18只,随机分为假手术组、盲肠结扎穿孔(CLP)脓毒症模型组和CLP+Nec-1干预组,每组6只。

处置流程与药物剂量

  • CLP+Nec-1组于造模前10分钟静脉注射Necrostatin-1溶液,剂量20 mg/kg。
  • 术后第2天以断颈方式处死小鼠,采集血清和肺组织样本。

研究设计与关键结果

  • HE染色显示假手术组肺形态结构正常;CLP组肺泡腔及间质充血水肿、中性粒细胞浸润、肺泡壁增厚;CLP+Nec-1组肺组织病理学改变优于CLP组。
  • 与假手术组比较,CLP组肺组织含水量[(88.00±0.00)% vs.(78.00±0.01)%]、肺血管通透性[伊文思蓝含量(mg/L):11.82±1.15 vs. 4.00±0.71]、肺组织p-MLKL与NLRP3蛋白表达(p-MLKL/GAPDH:0.34±0.04 vs. 0.12±0.01,NLRP3/GAPDH:0.47±0.07 vs. 0.16±0.04)及血清IL-1β水平(ng/L:183.56±9.61 vs. 44.14±6.95)均显著升高(均P<0.01)。
  • 与CLP组比较,CLP+Nec-1组肺组织含水量[(81.00±0.01)% vs.(88.00±0.00)%]、肺血管通透性[伊文思蓝含量(mg/L):7.90±0.00 vs. 11.82±1.15]、肺组织p-MLKL与NLRP3蛋白表达(p-MLKL/GAPDH:0.13±0.03 vs. 0.34±0.04,NLRP3/GAPDH:0.18±0.04 vs. 0.47±0.07)及血清IL-1β水平(ng/L:113.81±6.62 vs. 183.56±9.61)均显著降低(均P<0.01)。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠CLP脓毒症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,MLKL-NLRP3介导的坏死性炎症在脓毒症小鼠肺组织中显著上调,可被特异性抑制剂Necrostatin-1减轻。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the roles and underlying mechanisms of mixed lineage kinase domain like (MLKL)-mediated inflammatory response induced by NOD-like receptor protein 3 (NLRP3) inflammatory corpuscles in the acute lung injury (ALI) after sepsis.

METHODS: Eighteen BALB/c mice were randomly divided into sham operation group (Sham group), cecal ligation and perforation (CLP)-induced sepsis model group (CLP group) and specific inhibitor Necrostatin-1 intervention group [CLP+Nec-1 group, Necrostatin-1 solution (20 mg/kg) was injected intravenously 10 minutes before modeling], with 6 mice in each group. The mice were sacrificed by neck amputation at the 2nd day after operation, and the serum and lung tissue samples were collected. The morphological changes of lung tissue were observed by hematoxylin-eosin (HE) staining. The water content of lung tissue was detected by dry-wet weight method. The pulmonary vascular permeability was measured by Evans blue (EB) staining. The protein expressions of MLKL and NLRP3 in the lung tissue were detected by Western blotting, and the level of serum interleukin-1β (IL-1β) was detected by enzyme linked immunosorbent assay (ELISA).

RESULTS: HE staining showed that the lung morphological structure in Sham group was normal. In CLP group, congestion and edema in the alveolar cavity and interstitium, infiltration of neutrophils and thickening of alveolar wall were observed. The histopathological changes of lung tissue in CLP+Nec-1 group were better than those in CLP group. Compared with Sham group, the water content of lung tissue [(88.00±0.00)% vs. (78.00±0.01)%], pulmonary vascular permeability [EB content (mg/L): 11.82±1.15 vs. 4.00±0.71], the protein expressions of phosphorylated MLKL (p-MLKL) and NLRP3 in lung tissue (p-MLKL/GAPDH: 0.34±0.04 vs. 0.12±0.01,NLRP3/GAPDH: 0.47±0.07 vs. 0.16±0.04), and the level of serum IL-1β (ng/L: 183.56±9.61 vs. 44.14±6.95) in CLP group were all significantly increased (all P < 0.01). Compared with CLP group, the water content of lung tissue [(81.00±0.01)% vs. (88.00±0.00)%], pulmonary vascular permeability [EB content (mg/L): 7.90±0.00 vs. 11.82±1.15], protein expressions of p-MLKL and NLRP3 in lung tissue (p-MLKL/GAPDH: 0.13±0.03 vs. 0.34±0.04, NLRP3/GAPDH: 0.18±0.04 vs. 0.47±0.07), and the level of serum IL-1β (ng/L: 113.81±6.62 vs. 183.56±9.61) were all significantly decreased (all P < 0.01).

CONCLUSIONS: MLKL-NLRP3-mediated necroinflammation was significantly up-regulatedin the lung tissue of septic mice, which could be attenuated by specific inhibitor Necrostatin-1.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li N, Zhu X, Cheng Y, et al. [Role and mechanisms of MLKL-NLRP3-mediated necroinflammation in mice with sepsis-induced acute lung injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34112286. doi:10.3760/cma.j.cn121430-20200622-00483

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。